{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:55:46Z","timestamp":1783115746784,"version":"3.54.6"},"reference-count":78,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,12,17]],"date-time":"2017-12-17T00:00:00Z","timestamp":1513468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Amgen Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Research Synthesis Methods"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>A network meta\u2010analysis allows a simultaneous comparison between treatments evaluated in randomised controlled trials that share at least one treatment with at least one other study. Estimates of treatment effects may be required for treatments across disconnected networks of evidence, which requires a different statistical approach and modelling assumptions to account for imbalances in prognostic variables and treatment effect modifiers between studies. In this paper, we review and discuss methods for comparing treatments evaluated in studies that form disconnected networks of evidence. Several methods have been proposed but assessing which are appropriate often depends on the clinical context as well as the availability of data. Most methods account for sampling variation but do not always account for others sources of uncertainty. We suggest that further research is required to assess the properties of methods and the use of approaches that allow the incorporation of external information to reflect parameter and structural uncertainty.<\/jats:p>","DOI":"10.1002\/jrsm.1278","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T20:16:37Z","timestamp":1509048997000},"page":"148-162","source":"Crossref","is-referenced-by-count":26,"title":["A review of methods for comparing treatments evaluated in studies that form disconnected networks of evidence"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-7209","authenticated-orcid":false,"given":"John W.","family":"Stevens","sequence":"first","affiliation":[{"name":"School of Health and Related Research University of Sheffield  Regent Court, 30 Regent Street Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Amgen Ltd, Global Biostatistical Science  240 Cambridge Science Park, Milton Road Cambridge Cambridgeshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Downey","sequence":"additional","affiliation":[{"name":"Amgen Ltd, Global Biostatistical Science  240 Cambridge Science Park, Milton Road Cambridge Cambridgeshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-2516","authenticated-orcid":false,"given":"Anthea","family":"Sutton","sequence":"additional","affiliation":[{"name":"School of Health and Related Research University of Sheffield  Regent Court, 30 Regent Street Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,17]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"National Institute for Health and Care Excellence.Single technology appraisal: user guide for company evidence submission template2015http:\/\/www.nice.org.uk\/article\/pmg24."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4663"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3377"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12458724"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7387.472"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1184"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13485156"},{"key":"e_1_2_9_9_1","unstructured":"FariaR Hernandez\u2010AlavaM MancaA WailooA.NICE DSU Technical Support Document 17: the use of observational data to inform estimates of treatment effectiveness in technology appraisal; Methods for comparative individual data[Online]2015. Available:http:\/\/scharr.dept.shef.ac.uk\/nicedsu\/wp\u2010content\/uploads\/sites\/7\/2016\/03\/TSD17\u2010DSU\u2010Observational\u2010data\u2010FINAL.pdf[Accessed 22 May 2017]."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-010-9152-6"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2165\/11537420-000000000-00000"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001844"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0271-1"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.7837"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.256"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.242"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-014-0023-5"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3246"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/11538370-000000000-00000"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0007-0"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12219"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.69"},{"key":"e_1_2_9_24_1","first-page":"S141","article-title":"Fasting glucose model\u2010based meta\u2010analysis: a tool for designing and interpreting early diabetes studies","volume":"40","author":"Denney WS","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0427"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.587119"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.668097"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3243"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011420153"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.810211"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-011-9238-9"},{"issue":"2","key":"e_1_2_9_32_1","first-page":"110","article-title":"The efficacy of placebo\u2010adjusted taspoglutide on body weight reduction in clinical trials","volume":"70","author":"Li H\u2010Q","year":"2015","journal-title":"Pharmazie"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2014.11.008"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3795"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.122"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1214\/13-AOAS655"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6045"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.02.011"},{"key":"e_1_2_9_39_1","first-page":"S45","article-title":"Model\u2010based meta\u2010analysis informs phase 3 head\u2010to\u2010head trial simulations of brodalumab and competitors in psoriasis","volume":"40","author":"Salinger DH","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.977992"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.05.004"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.576238"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.2165\/11592490-000000000-00000"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0102-x"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.647309"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1863"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1874"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23330"},{"key":"e_1_2_9_49_1","first-page":"S18","article-title":"Model based meta\u2010analysis of Children's Depression Rating Scale: Revised (CDRS\u2010R) in children and adolescents with major depressive disorder","volume":"40","author":"Zhou D","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"e_1_2_9_50_1","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.E10 choice of control group and related issues in clinical trials2000."},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12242"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.1589"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/0470092602"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/0470033312"},{"key":"e_1_2_9_55_1","unstructured":"AbramsK BujkiewiczS DequenP JenkinsD MartinaR.GetReal \u2010 Project No. 115546 WP1: Deliverable 1.5 (Case Study Review: Rheumatoid Arthritis)[Online].2016. Available:https:\/\/www.imi\u2010getreal.eu\/Portals\/1\/Documents\/01%20WP1%20deliverables\/Deliverable%20Report%20D1.5_Rheumatoid%20Arthritis_websiteversion.pdf[Accessed]."},{"key":"e_1_2_9_56_1","unstructured":"DiasS WeltonNJ SuttonAJ AdesAE. last updated April 2012.NICE DSU technical Support Document 1: Introduction to evidence synthesis for decision making[Online]2011. Available: available fromhttp:\/\/www.nicedsu.org.uk[Accessed 31 October 2016]."},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1204"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2010.00673.x"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/rssa.12094"},{"key":"e_1_2_9_60_1","unstructured":"PhillippoDM AdesAE DiasS PalmerS AbramsKR WeltonNJ.NICE DSU Technical Support Document 18: Methods for population\u2010adjusted indirect comparisons in submissions to NICE. [Online]2016. Available:http:\/\/scharr.dept.shef.ac.uk\/nicedsu\/technical\u2010support\u2010documents\/population\u2010adjusted\u2010indirect\u2010comparisons\u2010maic\u2010and\u2010stc\/[Accessed 24 May 2017]."},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.8580"},{"key":"e_1_2_9_62_1","unstructured":"National Institute for Health and Care Excellence.NICE technology appraisal guidance 319: Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma[Online]2014. Available:https:\/\/www.nice.org.uk\/guidance\/TA319\/documents\/melanoma\u2010previously\u2010untreated\u2010unresectable\u2010stage\u2010iii\u2010or\u2010iv\u2010ipilimumab\u2010id74\u2010evaluation\u2010report[Accessed 31 October 2016]."},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0313-x"},{"key":"e_1_2_9_64_1","first-page":"81","article-title":"Weighting methods","volume":"19","author":"Kalton G","year":"2003","journal-title":"J Off Stat"},{"key":"e_1_2_9_65_1","doi-asserted-by":"crossref","unstructured":"McgarryLJ YangM ChiroliS LustgartenS DorerDJ.Indirect comparison of efficacy of ponatinib versus bosutinib in 3rd\u2010line chronic phase chronic myeloid leukemia using iterative proportional fitting[Online]2016. Available:https:\/\/www.ispor.org\/research_pdfs\/52\/pdffiles\/PCN21.pdf[Accessed 24 November 2016].","DOI":"10.1016\/j.jval.2016.03.1643"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1214\/09-STS313"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280215584401"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/pan\/mpr025"},{"key":"e_1_2_9_69_1","unstructured":"HappichM BrnabicA FariesD et al.Reweighting RCT evidence to better reflect real life: a case study of the innovation medicines initiative[Online]2016. Available:https:\/\/www.imi\u2010getreal.eu\/Portals\/1\/Documents\/Presentations\/Happich%20et%20al%20\u2010%20Reweighting%20RCT%20evidence%20to%20better%20reflect%20real%20life.pdf[Accessed 24 November 2016]."},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1515\/1557-4679.1382"},{"key":"e_1_2_9_71_1","unstructured":"BelgerM BrnabicA KadziolaZ PettoH FariesD.Alternative weighting approaches for matching adjusted indirect comparisons (MAIC). (Abstract).. ISPOR 20th Annual International Meeting Philadelphia PA USA2015a."},{"key":"e_1_2_9_72_1","doi-asserted-by":"crossref","unstructured":"BelgerM BrnabicA KadziolaZ PettoH FariesD.Inclusion of multiple studies in matching adjusted indirect comparisons (MAIC). (Abstract).. ISPOR 20th Annual International Meeting Philadelphia PA USA2015b.","DOI":"10.1016\/j.jval.2015.03.196"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.53"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12091"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-92"},{"key":"e_1_2_9_76_1","unstructured":"National Institute for Health and Care Excellence.Waldenstrom's macroglobulinaemia\u2014ibrutinib [ID884][Online]2016b. [Accessed 24 November 2016]."},{"key":"e_1_2_9_77_1","unstructured":"National Institute for Health and Care Excellence.Ledipasivir\u2010sofosbuvir for treating chronic hepatitis C[Online]2016a. Available:https:\/\/www.nice.org.uk\/guidance\/ta363[Accessed]."},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2008.00552.x"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/asw025"}],"container-title":["Research Synthesis Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjrsm.1278","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jrsm.1278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:38:17Z","timestamp":1695479897000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jrsm.1278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,17]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1002\/jrsm.1278"],"URL":"https:\/\/doi.org\/10.1002\/jrsm.1278","archive":["Portico"],"relation":{},"ISSN":["1759-2879","1759-2887"],"issn-type":[{"value":"1759-2879","type":"print"},{"value":"1759-2887","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,17]]}}}